A prospective randomized trial examining health care utilization in individuals using multiple smartphone-enabled biosensors.

Source: Bloss, C. S., et al. (2016). - Pubmed ID: 26788432

Setting: USA, Hospital

Study design:

RCT

Follow up: 6 months

Patient group:

Sample size:

Total: 160 (130)

IG: 75(65)

CG: 85(65)

Inclusion criteria:

One of three study conditions: hypertension, diabetes and/or cardiac arrhythmia

Type of technology:

Home monitoring

– Blood pressure

– Blood glucose

– ECG

– smartphone or computer for data transfer

 

App

– Data monitoring

– Education

Intervention:

Intervention:

Patients were trained on how to use app and medical devices and asked to take readings according to their condition. Data uploaded to app available for nurses. If poor monitor compliance nurses would send a reminder (email).

Chronic disease education available at app.

Duration:  6 months

Add on: NA

 

Control group:

Medical education and wellness information with regard to disease prevention and management.

Clinical effect/ Patient safety:

Clinical effect:

– Health insurance claims →

– self efficacy →

– patient activation →

– Bp (sys) →

– Bp (dia) →

– HemoglobinA1c → 

Patient safety:

NA

Patient experiences/ Staff experiences:

Patient experiences:Total use of one of the monitor device in study period: 10,305 times

Total Bp: 6356  times (avg 151)

Total BG: 3440 times (avg 248)

Arrhythmia: 509 (avg 57)

Staff experiences: NA

Costs and organization:

Investment:

Equipment

– relevant monitor equipment

Staff resources

– development of online management platform/application

Running:

Staff resources

– Training pt.

– monitoring

– technical service

Organization:

Health care utilization:

– Inpatient stays →

– emergency room visits →

– pharmacy claims →

Scroll to Top

Information

“↑”: Statistically significant increase

“↓”: Statistically significant decrease

“→”: Statistically insignificant (no difference)